Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Combined Ezetimibe and Atorvastatin Therapy on Coronary Thin-cap Fibroatheroma
NCT02588235Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in coronary artery disease (CAD), sponsored by Xijing Hospital. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02588235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02588235.